Collegium Pharmaceutical, Inc. is a pharmaceutical company, which engages in development and planning to commercialize next generation, abuse-deterrent products for the treatment of patients ...

4 analysts have shared their evaluations of Collegium Pharmaceutical COLL during the recent three months, expressing a mix of bullish and bearish perspectives. The table below provides a snapshot ...

STOUGHTON, Mass., April 03, 2024 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company committed to improving the lives of ...

STOUGHTON, Mass., April 11, 2024 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) (the “Company”), a leading, diversified specialty pharmaceutical company committed to ...

In our content, we occasionally include affiliate links. Should you click on these links, we may earn a commission, though this incurs no additional cost to you. Your use of this website signifies ...

The most recent trading session ended with Collegium Pharmaceutical (COLL) standing at $38.79, reflecting a -1.6% shift from the previouse trading day's closing. The stock's performance was behind ...

Maximum loss and profit are limited with a covered call strategy Tim Smith has 20+ years of experience in the financial services industry, both as a writer and as a trader. Ryan Eichler holds a B ...

The average Social Security benefit was just $1,911 as of Feb. 2024 -- well below the $4,873 maximum benefit. Workers need to sustain a very high income over the length of their career to qualify ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...